by admin | Dec 14, 2020 | Healthcare
IMAP is pleased to announce that OSE Immunotherapeutics successfully raised €18.6 million from 25 qualified French and international investors, through a private placement of new shares in its first fundraising since its IPO in 2015. OSE Immunotherapeutics is an...
by admin | Nov 7, 2020 | Healthcare
BIOGROUP has acquired CMA-Medina, the leading player in medical lab testing in Belgium. This is BIOGROUP’s first acquisition abroad, and part of a strategy to become a leading European player through expansion into other countries, while continuing its development in...
by admin | Oct 13, 2020 | Healthcare
Since the beginning of the month Ruta Hildebrand strengthens IMAP M&A Consultants AG as a partner. Ruta Hildebrand has more than 10 years of professional experience in M&A and corporate finance consulting. Based at the IMAP office in Munich, she will be...
by admin | Sep 10, 2020 | Healthcare
IMAP is pleased to announce that BIOGROUP has acquired Dyomedea-Neolab. Majority-owned by biologists, Dyomedea-Neolab is a major player in medical lab testing in the Auvergne-Rhône-Alpes region. Operating 43 laboratories, mainly in the Rhône department, it generated...
by admin | Aug 5, 2020 | Healthcare
IMAP is pleased to announce that BIOGROUP has acquired Laborizon Group. Majority-owned by biologists and supported by its management and BPIFrance for the past 4 years, Laborizon Group is leader in medical lab testing in Western France. Operating 105 laboratories in...
by admin | Jul 14, 2020 | Healthcare
IMAP is pleased to announce that BIOGROUP closed a new €275 million non-fungible Term Loan B add-on at E+425, with a 0% floor priced at 97. BIOGROUP is the French leader of routine medical diagnostics with 2019 pro forma run-rate sales of c.€850 million. The Term Loan...
Recent Comments